| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |